Clinical Trial Update: Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI [NA]

View source ↗

Summary

Clinical trial update on using FibroX AI to improve primary-care diagnosis of liver fibrosis in MASLD; the study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Metabolic Dysfunction-associated Steatotic Liver Disease

Drugs mentioned

• FibroX AI

Snippet

Sponsor: Yale University | Conditions: MASLD, Fibrosis of Liver | NA | Status: NOT_YET_RECRUITING